246 related articles for article (PubMed ID: 11752702)
1. Sequence analysis of the GP, NP, VP40 and VP24 genes of Ebola virus isolated from deceased, surviving and asymptomatically infected individuals during the 1996 outbreak in Gabon: comparative studies and phylogenetic characterization.
Leroy EM; Baize S; Mavoungou E; Apetrei C
J Gen Virol; 2002 Jan; 83(Pt 1):67-73. PubMed ID: 11752702
[TBL] [Abstract][Full Text] [Related]
2. Identification of continuous human B-cell epitopes in the VP35, VP40, nucleoprotein and glycoprotein of Ebola virus.
Becquart P; Mahlakõiv T; Nkoghe D; Leroy EM
PLoS One; 2014; 9(6):e96360. PubMed ID: 24914933
[TBL] [Abstract][Full Text] [Related]
3. Functional Characterization of Adaptive Mutations during the West African Ebola Virus Outbreak.
Dietzel E; Schudt G; Krähling V; Matrosovich M; Becker S
J Virol; 2017 Jan; 91(2):. PubMed ID: 27847361
[TBL] [Abstract][Full Text] [Related]
4. Isolation and phylogenetic characterization of Ebola viruses causing different outbreaks in Gabon.
Georges-Courbot MC; Sanchez A; Lu CY; Baize S; Leroy E; Lansout-Soukate J; Tévi-Bénissan C; Georges AJ; Trappier SG; Zaki SR; Swanepoel R; Leman PA; Rollin PE; Peters CJ; Nichol ST; Ksiazek TG
Emerg Infect Dis; 1997; 3(1):59-62. PubMed ID: 9126445
[TBL] [Abstract][Full Text] [Related]
5. Recombinant Modified Vaccinia Virus Ankara Generating Ebola Virus-Like Particles.
Schweneker M; Laimbacher AS; Zimmer G; Wagner S; Schraner EM; Wolferstätter M; Klingenberg M; Dirmeier U; Steigerwald R; Lauterbach H; Hochrein H; Chaplin P; Suter M; Hausmann J
J Virol; 2017 Jun; 91(11):. PubMed ID: 28331098
[TBL] [Abstract][Full Text] [Related]
6. Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells.
Ilinykh PA; Lubaki NM; Widen SG; Renn LA; Theisen TC; Rabin RL; Wood TG; Bukreyev A
J Virol; 2015 Aug; 89(15):7567-83. PubMed ID: 25972536
[TBL] [Abstract][Full Text] [Related]
7. Sequence analysis of the L protein of the Ebola 2014 outbreak: Insight into conserved regions and mutations.
Ayub G; Waheed Y
Mol Med Rep; 2016 Jun; 13(6):4821-6. PubMed ID: 27082438
[TBL] [Abstract][Full Text] [Related]
8. Recombinant Ebola virus nucleoprotein and glycoprotein (Gabon 94 strain) provide new tools for the detection of human infections.
Prehaud C; Hellebrand E; Coudrier D; Volchkov VE; Volchkova VA; Feldmann H; Le Guenno B; Bouloy M
J Gen Virol; 1998 Nov; 79 ( Pt 11)():2565-72. PubMed ID: 9820131
[TBL] [Abstract][Full Text] [Related]
9. Complete genome sequence of an Ebola virus (Sudan species) responsible for a 2000 outbreak of human disease in Uganda.
Sanchez A; Rollin PE
Virus Res; 2005 Oct; 113(1):16-25. PubMed ID: 16139097
[TBL] [Abstract][Full Text] [Related]
10. Emergence of subtype Zaire Ebola virus in Gabon.
Volchkov V; Volchkova V; Eckel C; Klenk HD; Bouloy M; LeGuenno B; Feldmann H
Virology; 1997 May; 232(1):139-44. PubMed ID: 9185597
[TBL] [Abstract][Full Text] [Related]
11. Contribution of ebola virus glycoprotein, nucleoprotein, and VP24 to budding of VP40 virus-like particles.
Licata JM; Johnson RF; Han Z; Harty RN
J Virol; 2004 Jul; 78(14):7344-51. PubMed ID: 15220407
[TBL] [Abstract][Full Text] [Related]
12. Persistence and genetic stability of Ebola virus during the outbreak in Kikwit, Democratic Republic of the Congo, 1995.
Rodriguez LL; De Roo A; Guimard Y; Trappier SG; Sanchez A; Bressler D; Williams AJ; Rowe AK; Bertolli J; Khan AS; Ksiazek TG; Peters CJ; Nichol ST
J Infect Dis; 1999 Feb; 179 Suppl 1():S170-6. PubMed ID: 9988181
[TBL] [Abstract][Full Text] [Related]
13. Emergence of Zaire Ebola virus disease in Guinea.
Baize S; Pannetier D; Oestereich L; Rieger T; Koivogui L; Magassouba N; Soropogui B; Sow MS; Keïta S; De Clerck H; Tiffany A; Dominguez G; Loua M; Traoré A; Kolié M; Malano ER; Heleze E; Bocquin A; Mély S; Raoul H; Caro V; Cadar D; Gabriel M; Pahlmann M; Tappe D; Schmidt-Chanasit J; Impouma B; Diallo AK; Formenty P; Van Herp M; Günther S
N Engl J Med; 2014 Oct; 371(15):1418-25. PubMed ID: 24738640
[TBL] [Abstract][Full Text] [Related]
14. An evolutionary insight into emerging Ebolavirus strains isolated in Africa.
Pereira-Gomez M; Lopez-Tort F; Fajardo A; Cristina J
J Med Virol; 2020 Aug; 92(8):988-995. PubMed ID: 31702053
[TBL] [Abstract][Full Text] [Related]
15. Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 Proteins.
Lázaro-Frías A; Gómez-Medina S; Sánchez-Sampedro L; Ljungberg K; Ustav M; Liljeström P; Muñoz-Fontela C; Esteban M; García-Arriaza J
J Virol; 2018 Jun; 92(11):. PubMed ID: 29514907
[No Abstract] [Full Text] [Related]
16. Analysis of CD8
Sakabe S; Sullivan BM; Hartnett JN; Robles-Sikisaka R; Gangavarapu K; Cubitt B; Ware BC; Kotliar D; Branco LM; Goba A; Momoh M; Sandi JD; Kanneh L; Grant DS; Garry RF; Andersen KG; de la Torre JC; Sabeti PC; Schieffelin JS; Oldstone MBA
Proc Natl Acad Sci U S A; 2018 Aug; 115(32):E7578-E7586. PubMed ID: 30038008
[TBL] [Abstract][Full Text] [Related]
17. Multiple Ebola virus transmission events and rapid decline of central African wildlife.
Leroy EM; Rouquet P; Formenty P; Souquière S; Kilbourne A; Froment JM; Bermejo M; Smit S; Karesh W; Swanepoel R; Zaki SR; Rollin PE
Science; 2004 Jan; 303(5656):387-90. PubMed ID: 14726594
[TBL] [Abstract][Full Text] [Related]
18. New Perspectives on Ebola Virus Evolution.
Brown CJ; Quates CJ; Mirabzadeh CA; Miller CR; Wichman HA; Miura TA; Ytreberg FM
PLoS One; 2016; 11(8):e0160410. PubMed ID: 27479005
[TBL] [Abstract][Full Text] [Related]
19. Vaccine potential of Ebola virus VP24, VP30, VP35, and VP40 proteins.
Wilson JA; Bray M; Bakken R; Hart MK
Virology; 2001 Aug; 286(2):384-90. PubMed ID: 11485406
[TBL] [Abstract][Full Text] [Related]
20. Rapid detection and quantification of Ebola Zaire virus by one-step real-time quantitative reverse transcription-polymerase chain reaction.
Ro YT; Ticer A; Carrion R; Patterson JL
Microbiol Immunol; 2017 Apr; 61(3-4):130-137. PubMed ID: 28332721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
